Literature DB >> 10559376

Identification of a novel sequence at the 3' end of the GB virus B genome.

A Sbardellati1, E Scarselli, L Tomei, A S Kekulé, C Traboni.   

Abstract

GB virus B (GBV-B) is a virus of the family Flaviviridae that infects small primates (Saguinus sp. [tamarins]) and shows similarities to hepatitis C virus (HCV) in genome organization, protein function, tissue tropism, and pathogenicity. This suggests the possibility of using tamarins infected by GBV-B or GBV-B/HCV chimeric viruses as a surrogate animal model of HCV infection. To achieve the construction of such chimeric viruses, it is essential to produce a complete and infectious GBV-B genomic RNA. We have identified a novel sequence at the 3' end of the GBV-B genome and show that it can be arranged in a secondary structure resembling that of the 3' end of the HCV genome, which is known to be essential for infectivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559376      PMCID: PMC113113     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

Review 2.  To C or not to C: these are the questions.

Authors:  H J Alter
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

3.  The new GB hepatitis viruses.

Authors:  A J Zuckerman
Journal:  Lancet       Date:  1995-06-10       Impact factor: 79.321

4.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.

Authors:  I Saito; T Miyamura; A Ohbayashi; H Harada; T Katayama; S Kikuchi; Y Watanabe; S Koi; M Onji; Y Ohta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus.

Authors:  M E Major; K Mihalik; J Fernandez; J Seidman; D Kleiner; A A Kolykhalov; C M Rice; S M Feinstone
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.

Authors:  A Weiner; A L Erickson; J Kansopon; K Crawford; E Muchmore; A L Hughes; M Houghton; C M Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions.

Authors:  F Deinhardt; A W Holmes; R B Capps; H Popper
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

8.  Lack of protective immunity against reinfection with hepatitis C virus.

Authors:  P Farci; H J Alter; S Govindarajan; D C Wong; R Engle; R R Lesniewski; I K Mushahwar; S M Desai; R H Miller; N Ogata
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

9.  Identification of two flavivirus-like genomes in the GB hepatitis agent.

Authors:  J N Simons; T J Pilot-Matias; T P Leary; G J Dawson; S M Desai; G G Schlauder; A S Muerhoff; J C Erker; S L Buijk; M L Chalmers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Molecular and serologic analysis in the transmission of the GB hepatitis agents.

Authors:  G G Schaluder; G J Dawson; J N Simons; T J Pilot-Matias; R A Gutierrez; C A Heynen; M F Knigge; G S Kurpiewski; S L Buijk; T P Leary
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

View more
  7 in total

1.  Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication.

Authors:  Peter Friebe; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Functional characterization of the genomic promoter of borna disease virus (BDV): implications of 3'-terminal sequence heterogeneity for BDV persistence.

Authors:  Debralee Rosario; Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.

Authors:  N Butkiewicz; N Yao; W Zhong; J Wright-Minogue; P Ingravallo; R Zhang; J Durkin; D N Standring; B M Baroudy; D V Sangar; S M Lemon; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Cell clones selected from the Huh7 human hepatoma cell line support efficient replication of a subgenomic GB virus B replicon.

Authors:  Amedeo De Tomassi; Maura Pizzuti; Rita Graziani; Andrea Sbardellati; Sergio Altamura; Giacomo Paonessa; Cinzia Traboni
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  In vivo analysis of the 3' untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin.

Authors:  Jae-Hwan Nam; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Marisa St Claire; Jens Bukh
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Hep3B human hepatoma cells support replication of the wild-type and a 5'-end deletion mutant GB virus B replicon.

Authors:  Amedeo De Tomassi; Maura Pizzuti; Cinzia Traboni
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA.

Authors:  Annette Martin; Francis Bodola; David V Sangar; Kathryn Goettge; Vsevolod Popov; Rene Rijnbrand; Robert E Lanford; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-07       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.